Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 474

1.

Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.

Miranda-Ribera A, Ennamorati M, Serena G, Cetinbas M, Lan J, Sadreyev RI, Jain N, Fasano A, Fiorentino M.

Front Immunol. 2019 Sep 19;10:2233. doi: 10.3389/fimmu.2019.02233. eCollection 2019.

2.

Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes.

Loforte A, Fiorentino M, Gliozzi G, Mariani C, Folesani G, Suarez SM, Russo A, Masetti M, Potena L, Pacini D.

Transplant Proc. 2019 Oct 10. pii: S0041-1345(19)30967-4. doi: 10.1016/j.transproceed.2019.07.013. [Epub ahead of print]

PMID:
31607616
3.

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.

Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M, Elfandy H, Syamala S, Karoly ED, Alshalalfa M, Erho N, Ross A, Schaeffer EM, Gibb EA, Takhar M, Den RB, Lehrer J, Karnes RJ, Freedland SJ, Davicioni E, Spratt DE, Ellis L, Jaffe JD, DʼAmico AV, Kantoff PW, Bradner JE, Mucci LA, Chavarro JE, Loda M, Brown M.

Nat Commun. 2019 Sep 25;10(1):4358. doi: 10.1038/s41467-019-12298-z.

4.

A prospective study of intraprostatic inflammation, focal atrophy, and progression to lethal prostate cancer.

Zhang Y, Zhou CK, Rencsok EM, Fall K, Lotan TL, Loda M, Giunchi F, Platz EA, De Marzo AM, Mucci LA, Fiorentino M, Ebot EM.

Cancer Epidemiol Biomarkers Prev. 2019 Sep 18. pii: cebp.0713.2019. doi: 10.1158/1055-9965.EPI-19-0713. [Epub ahead of print]

PMID:
31533941
5.

Liquid biopsies in urological cancers: what we need to know before starting using them.

Franceschini T, Giunchi F, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Fiorentino M.

Expert Rev Mol Diagn. 2019 Sep 11:1-5. doi: 10.1080/14737159.2019.1665508. [Epub ahead of print] No abstract available.

PMID:
31509027
6.

Ovine Abortion by Neospora caninum: First Case Reported in Argentina.

Hecker YP, Morrell EL, Fiorentino MA, Gual I, Rivera E, Fiorani F, Dorsch MA, Gos ML, Pardini LL, Scioli MV, Magariños S, Paolicchi FA, Cantón GJ, Moore DP.

Acta Parasitol. 2019 Sep 4. doi: 10.2478/s11686-019-00106-z. [Epub ahead of print]

PMID:
31485838
7.

Clinical significance of ROS1 5' deletions in non-small cell lung cancer.

Capizzi E, Dall'Olio FG, Gruppioni E, Sperandi F, Altimari A, Giunchi F, Fiorentino M, Ardizzoni A.

Lung Cancer. 2019 Sep;135:88-91. doi: 10.1016/j.lungcan.2019.07.017. Epub 2019 Jul 17.

PMID:
31447007
8.

A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time.

Trotta GF, Pellicciari R, Boccaccio A, Brunetti A, Cascarano GD, Manghisi VM, Fiorentino M, Uva AE, Defazio G, Bevilacqua V.

Comput Biol Med. 2019 Sep;112:103376. doi: 10.1016/j.compbiomed.2019.103376. Epub 2019 Jul 31.

PMID:
31386970
9.

New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes.

Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F.

Clin Genitourin Cancer. 2019 Oct;17(5):e871-e877. doi: 10.1016/j.clgc.2019.07.001. Epub 2019 Jul 8. Review.

PMID:
31378578
10.

Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum.

Fiorentino MD, Monteiro JMC, de Siqueira REB, Kim EIM, Curi AP, Ferrreira CR, Nardo M, de Campos FPF.

Autops Case Rep. 2019 Jul 12;9(3):e2019100. doi: 10.4322/acr.2019.100. eCollection 2019 Jul-Sep.

11.

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia.

Broccoli A, Bertuzzi C, Fiorentino M, Morigi A, Stefoni V, Agostinelli C, Argnani L, Cavo M, Zinzani PL.

Onco Targets Ther. 2019 Jun 20;12:4807-4812. doi: 10.2147/OTT.S202061. eCollection 2019.

12.

Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer.

Livi V, Ardizzoni A, Cancellieri A, Natali F, Ferrari M, Paioli D, De Biase D, Capizzi E, Tallini G, Fiorentino M, Trisolini R.

Clin Respir J. 2019 Sep;13(9):590-597. doi: 10.1111/crj.13063. Epub 2019 Aug 9.

PMID:
31343834
13.

A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.

Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F.

Mol Diagn Ther. 2019 Oct;23(5):569-577. doi: 10.1007/s40291-019-00414-0. Review.

PMID:
31332726
14.

The Decision-Making Process in Acute Type A Aortic Dissection: When to Replace the Aortic Arch.

Leone A, Di Marco L, Murana G, Coppola G, Fiorentino M, Amodio C, Di Bartolomeo R, Pacini D.

Semin Thorac Cardiovasc Surg. 2019 Jun 14. pii: S1043-0679(18)30403-9. doi: 10.1053/j.semtcvs.2019.05.036. [Epub ahead of print] Review.

PMID:
31207295
15.

Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Patients Aged 70 Years or Older.

Biancari F, Saeed D, Fiore A, Dalén M, Ruggieri VG, Jónsson K, Gatti G, Zipfel S, Dell'Aquila AM, Chocron S, Bounader K, Amr G, Settembre N, Pälve K, Loforte A, Gabrielli M, Livi U, Lechiancole A, Pol M, Netuka I, Spadaccio C, Pettinari M, De Keyzer D, Reichart D, Ragnarsson S, Alkhamees K, Lichtenberg A, Fux T, El Dean Z, Fiorentino M, Mariscalco G, Jeppsson A, Welp H, Perrotti A.

Ann Thorac Surg. 2019 Oct;108(4):1257-1264. doi: 10.1016/j.athoracsur.2019.04.063. Epub 2019 Jun 8. Review.

PMID:
31185202
16.

Less invasive ventricular enhancement (LIVE) as potential therapy for ischaemic cardiomyopathy end-stage heart failure.

Loforte A, Alfonsi J, Gliozzi G, Folesani G, Fiorentino M, Biffi M, Marinelli G, Di Bartolomeo R, Pacini D.

J Thorac Dis. 2019 Apr;11(Suppl 6):S921-S928. doi: 10.21037/jtd.2019.02.86.

17.

Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey.

Fiorentino M, Sagaon-Teyssier L, Ndiaye K, Suzan-Monti M, Mengue MT, Vidal L, Kuaban C, March L, Laurent C, Spire B, Boyer S; EVOLCam Study Group.

Womens Health (Lond). 2019 Jan-Dec;15:1745506519848546. doi: 10.1177/1745506519848546.

18.

BAP1 in solid tumors.

Di Nunno V, Frega G, Santoni M, Gatto L, Fiorentino M, Montironi R, Battelli N, Brandi G, Massari F.

Future Oncol. 2019 Jun;15(18):2151-2162. doi: 10.2217/fon-2018-0915. Epub 2019 Jun 4.

PMID:
31159579
19.

Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence.

Bianchi L, Schiavina R, Borghesi M, Casablanca C, Chessa F, Mineo Bianchi F, Pultrone C, Vagnoni V, Ercolino A, Dababneh H, Fiorentino M, Brunocilla E.

Minerva Urol Nefrol. 2019 May 28. doi: 10.23736/S0393-2249.19.03269-7. [Epub ahead of print]

PMID:
31144486
20.

BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma.

Repaci A, Vicennati V, Paccapelo A, Cavicchi O, Salituro N, Monari F, de Biase D, Tallini G, Altimari A, Gruppioni E, Fiorentino M, Pagotto U.

Int J Endocrinol. 2019 Apr 7;2019:3081497. doi: 10.1155/2019/3081497. eCollection 2019.

21.

Plasma Biomarkers in Predicting Renal Recovery from Acute Kidney Injury in Critically Ill Patients.

Fiorentino M, Tohme FA, Murugan R, Kellum JA.

Blood Purif. 2019;48(3):253-261. doi: 10.1159/000500423. Epub 2019 May 10.

PMID:
31079110
22.

PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma.

Carlsson J, Sundqvist P, Kosuta V, Fält A, Giunchi F, Fiorentino M, Davidsson S.

Appl Immunohistochem Mol Morphol. 2019 May 1. doi: 10.1097/PAI.0000000000000766. [Epub ahead of print]

PMID:
31058656
23.

PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes.

Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O.

Eur Urol Oncol. 2019 Mar;2(2):214-221. doi: 10.1016/j.euo.2018.07.010. Epub 2018 Aug 23.

PMID:
31017099
24.

First case report of Toxoplasma gondii-induced abortions and stillbirths in sheep in Argentina.

Gual I, Giannitti F, Hecker YP, Shivers J, Entrocassi AC, Morrell EL, Pardini L, Fiorentino MA, Rodríguez Fermepin M, Unzaga JM, Cantón GJ, Venturini MC, Moore DP.

Vet Parasitol Reg Stud Reports. 2018 May;12:39-42. doi: 10.1016/j.vprsr.2018.01.001. Epub 2018 Jan 11.

PMID:
31014806
25.

RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis.

Leonard MM, Bai Y, Serena G, Nickerson KP, Camhi S, Sturgeon C, Yan S, Fiorentino MR, Katz A, Nath B, Richter J, Sleeman M, Gurer C, Fasano A.

PLoS One. 2019 Apr 18;14(4):e0215132. doi: 10.1371/journal.pone.0215132. eCollection 2019.

26.

Outflow graft tunneling through the transverse sinus for HeartWare HVAD implantation as bridge to heart transplantation strategy.

Loforte A, Gliozzi G, Coppola G, Fiorentino M, Martin Suarez S, Pacini D.

Multimed Man Cardiothorac Surg. 2019 Apr 12;2019. doi: 10.1510/mmcts.2019.012.

27.

The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma.

Carlsson J, Christiansen J, Davidsson S, Giunchi F, Fiorentino M, Sundqvist P.

Oncol Lett. 2019 May;17(5):4566-4574. doi: 10.3892/ol.2019.10142. Epub 2019 Mar 12.

28.

Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.

Zelic R, Zugna D, Bottai M, Andrén O, Fridfeldt J, Carlsson J, Davidsson S, Fiano V, Fiorentino M, Giunchi F, Grasso C, Lianas L, Mascia C, Molinaro L, Zanetti G, Richiardi L, Pettersson A, Akre O.

Am J Epidemiol. 2019 Jun 1;188(6):1165-1173. doi: 10.1093/aje/kwz026.

PMID:
30976789
29.

The Metabolic Landscape of Prostate Cancer.

Giunchi F, Fiorentino M, Loda M.

Eur Urol Oncol. 2019 Feb;2(1):28-36. doi: 10.1016/j.euo.2018.06.010. Epub 2018 Jul 19. Review.

PMID:
30929843
30.

Percutaneous Pulmonary Artery Venting via Jugular Vein While on Peripheral Extracorporeal Life Support.

Loforte A, Baiocchi M, Dal Checco E, Gliozzi G, Fiorentino M, Lo Coco V, Martin Suarez S, Marrozzini C, Biffi M, Marinelli G, Pacini D.

ASAIO J. 2019 Mar 19. doi: 10.1097/MAT.0000000000000991. [Epub ahead of print]

PMID:
30908287
31.

Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.

Urbini M, Indio V, Tarantino G, Ravegnini G, Angelini S, Nannini M, Saponara M, Santini D, Ceccarelli C, Fiorentino M, Vincenzi B, Fumagalli E, Casali PG, Grignani G, Pession A, Ardizzoni A, Astolfi A, Pantaleo MA.

Genes Chromosomes Cancer. 2019 Sep;58(9):636-642. doi: 10.1002/gcc.22753. Epub 2019 Apr 16.

32.

Corrigendum: Aquaporin-9 Contributes to the Maturation Process and Inflammatory Cytokine Secretion of Murine Dendritic Cells.

De Santis S, Serino G, Fiorentino MR, Galleggiante V, Gena P, Verna G, Liso M, Massaro M, Lan J, Troisi J, Cataldo I, Bertamino A, Pinto A, Campiglia P, Santino A, Giannelli G, Fasano A, Calamita G, Chieppa M.

Front Immunol. 2019 Feb 25;10:216. doi: 10.3389/fimmu.2019.00216. eCollection 2019.

33.

Role and management of extracorporeal life support after surgery of chronic thromboembolic pulmonary hypertension.

Martin-Suarez S, Gliozzi G, Fiorentino M, Loforte A, Ghigi V, Di Camillo M, Galiè N, Pacini D.

Ann Cardiothorac Surg. 2019 Jan;8(1):84-92. doi: 10.21037/acs.2019.01.02.

34.

Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study.

Pesce F, Martino M, Fiorentino M, Rollo T, Simone S, Gallo P, Stallone G, Grandaliano G, Schena A, Margiotta M, Mininni D, Palieri R, Lucarelli G, Battaglia M, Gesualdo L, Castellano G.

J Nephrol. 2019 Aug;32(4):661-668. doi: 10.1007/s40620-019-00591-5. Epub 2019 Jan 30.

PMID:
30701457
35.

Updates on urinary tract infections in kidney transplantation.

Fiorentino M, Pesce F, Schena A, Simone S, Castellano G, Gesualdo L.

J Nephrol. 2019 Oct;32(5):751-761. doi: 10.1007/s40620-019-00585-3. Epub 2019 Jan 28. Review.

PMID:
30689126
36.

Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer.

Capizzi E, Ricci C, Giunchi F, Zagnoni S, Ceccarelli C, Gómez BUÁ, Casolari L, Gelsomino F, Trisolini R, Fiorentino M, Ardizzoni A.

Lung Cancer. 2018 Dec;126:9-14. doi: 10.1016/j.lungcan.2018.10.017. Epub 2018 Oct 17.

PMID:
30527198
37.

Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies.

Carlsson J, Davidsson S, Fridfeldt J, Giunchi F, Fiano V, Grasso C, Zelic R, Richiardi L, Andrén O, Pettersson A, Fiorentino M, Akre O.

BMC Med Res Methodol. 2018 Dec 5;18(1):161. doi: 10.1186/s12874-018-0628-1.

38.

Persistent Mullerian duct syndrome: Report of two cases with phenotypical immunohistochemical profiling.

Ambrosi F, Fiorentino M, Chessa F, Brunocilla E, D'Errico A, Bertuzzo RV, Giunchi F.

Urologia. 2018 Nov;85(4):177-181. doi: 10.1177/0391560317749426. Epub 2018 Mar 28.

PMID:
30426882
39.

Unusual metastatic localization to the kidney of basaloid squamous cell carcinoma of the oropharynx.

Ricci C, Rossi MS, De Stefano R, Fiorentino M, Vasuri F.

Urologia. 2018 Nov;85(4):182-185. doi: 10.1177/0391560317749423. Epub 2018 Mar 23.

PMID:
30426881
40.

Emerging Molecular Technologies in Genitourinary Tumors.

Giunchi F, Cimadamore A, Fiorentino M.

Front Oncol. 2018 Oct 30;8:489. doi: 10.3389/fonc.2018.00489. eCollection 2018. No abstract available.

41.

Aquaporin 9 Contributes to the Maturation Process and Inflammatory Cytokine Secretion of Murine Dendritic Cells.

De Santis S, Serino G, Fiorentino MR, Galleggiante V, Gena P, Verna G, Liso M, Massaro M, Lan J, Troisi J, Cataldo I, Bertamino A, Pinto A, Campiglia P, Santino A, Giannelli G, Fasano A, Calamita G, Chieppa M.

Front Immunol. 2018 Oct 16;9:2355. doi: 10.3389/fimmu.2018.02355. eCollection 2018. Erratum in: Front Immunol. 2019 Feb 25;10:216.

42.

A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.

Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.

Eur Urol. 2019 Jul;76(1):33-40. doi: 10.1016/j.eururo.2018.09.041. Epub 2018 Oct 6.

PMID:
30301696
43.

MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.

Rihawi K, Alfieri R, Fiorentino M, Fontana F, Capizzi E, Cavazzoni A, Terracciano M, La Monica S, Ferrarini A, Buson G, Petronini PG, Ardizzoni A.

Transl Oncol. 2019 Jan;12(1):116-121. doi: 10.1016/j.tranon.2018.09.013. Epub 2018 Oct 2.

44.

Predictive markers in lung cancer: a few hints for the practicing pathologist.

Barbareschi M, Barberis M, Buttitta F, Doglioni C, Fiorentino M, Fontanini G, Franco R, Marchetti A, Rossi G, Troncone G.

Pathologica. 2018 Mar;110(1):29-38. Review.

PMID:
30259911
45.

Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.

Isidori F, Malvi D, Fittipaldi S, Forcato C, Bozzarelli I, Sala C, Raulli G, D'Errico A, Fiorentino M, Seri M, Krishnadath KK, Bonora E, Mattioli S; EAC-BAGH group.

BMC Cancer. 2018 Sep 12;18(1):889. doi: 10.1186/s12885-018-4789-4.

46.

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.

Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP).

Carcinogenesis. 2018 Dec 31;39(12):1431-1437. doi: 10.1093/carcin/bgy112.

PMID:
30165429
47.

Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer.

Di Nunno V, Cimadamore A, Santoni M, Scarpelli M, Fiorentino M, Ciccarese C, Iacovelli R, Cheng L, Lopez-Beltran A, Massari F, Montironi R.

Future Oncol. 2018 Oct;14(25):2559-2564. doi: 10.2217/fon-2018-0158. Epub 2018 Aug 24. No abstract available.

48.

Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors.

DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA; Transdisciplinary Prostate Cancer Partnership(ToPCaP).

Prostate. 2018 Nov;78(15):1172-1180. doi: 10.1002/pros.23692. Epub 2018 Jul 15.

PMID:
30009541
49.

Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.

Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D'Errico A, de Biase D.

World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647. Review.

50.

Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden.

Grabowska B, Ulvskog E, Carlsson J, Fiorentino M, Giunchi F, Lindblad P, Sundqvist P.

Scand J Urol. 2018 Jun;52(3):206-212. doi: 10.1080/21681805.2018.1430706. Epub 2018 Jul 4.

PMID:
29972347

Supplemental Content

Loading ...
Support Center